Analyst Ratings for Zentalis Pharmaceuticals (ZNTL)
ZNTL Rating Summary
ZNTL Price Target Summary
- Highest: $11.00 (Rodman & Renshaw)
- Lowest: $2.00 (Leerink)
- Average: $7.22
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.22 (+151.6%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Avg. $ Target:
$7.22 (+151.6%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/15/2026 | William Blair | Matt Phipps | New Coverage | Outperform (N/A) |
N/A (N/A) |
3.50 (2.87) |
-18% | Details |
| 7/23/2026 | Rodman & Renshaw | Michael G. King, Jr | New Coverage | Buy (N/A) |
11.00 (N/A) |
4.50 (2.87) |
-36.22% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
